Free Trial

Induction Healthcare Group (INHC) Competitors

Induction Healthcare Group logo
GBX 9.75 0.00 (0.00%)
As of 06/18/2025

INHC vs. RENX, COG, FDBK, IQAI, TRLS, DVRG, SENS, EMIS, CRW, and INS

Should you be buying Induction Healthcare Group stock or one of its competitors? The main competitors of Induction Healthcare Group include Renalytix (RENX), Cambridge Cognition (COG), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), and Instem (INS). These companies are all part of the "health information services" industry.

Induction Healthcare Group vs. Its Competitors

Induction Healthcare Group (LON:INHC) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Induction Healthcare Group has a beta of -0.41, suggesting that its stock price is 141% less volatile than the S&P 500. Comparatively, Renalytix has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500.

In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Renalytix'saverage media sentiment score.

Company Overall Sentiment
Induction Healthcare Group Neutral
Renalytix Neutral

46.3% of Induction Healthcare Group shares are owned by institutional investors. Comparatively, 28.4% of Renalytix shares are owned by institutional investors. 54.6% of Induction Healthcare Group shares are owned by insiders. Comparatively, 35.7% of Renalytix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Induction Healthcare Group has a net margin of -40.70% compared to Renalytix's net margin of -1,191.75%. Renalytix's return on equity of 293.20% beat Induction Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Induction Healthcare Group-40.70% -26.97% -7.32%
Renalytix -1,191.75%293.20%-93.54%

Induction Healthcare Group has higher revenue and earnings than Renalytix. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Induction Healthcare Group£12.57M0.72-£5.12M-£5.54-1.76
Renalytix£9.22M3.03-£109.93M-£21.19-0.32

Summary

Induction Healthcare Group beats Renalytix on 7 of the 11 factors compared between the two stocks.

Get Induction Healthcare Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for INHC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INHC vs. The Competition

MetricInduction Healthcare GroupHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£9.00M£222.89M£5.56B£3.01B
Dividend YieldN/A6.68%5.25%5.02%
P/E Ratio-1.76356.0627.18149.15
Price / Sales0.72201.04440.78254,247.77
Price / Cash2.6847.1437.5027.97
Price / Book0.505.328.084.57
Net Income-£5.12M-£15.55M£3.16B£5.90B
7 Day PerformanceN/A0.90%3.77%7.46%
1 Month Performance4.00%-1.47%3.90%11.33%
1 Year Performance-15.22%13.48%34.22%81.12%

Induction Healthcare Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A-22.0%£9.00M£12.57M-1.7674
RENX
Renalytix
N/AGBX 7
0.0%
N/A-40.0%£29.01M£9.22M-0.33102Gap Down
High Trading Volume
COG
Cambridge Cognition
N/AGBX 33
+3.1%
N/A-15.0%£13.82M£15.64M-8.7780Gap Up
FDBK
Feedback
N/AGBX 14.30
-1.4%
N/A-77.6%£6.27M£3.88M-0.5824Positive News
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-27.3%£1.77M£538.19K-13.676Gap Up
TRLS
Trellus Health
N/AGBX 0.65
flat
N/A-64.4%£1.26M£65.83K-0.1931
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Negative News
Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
N/AGBX 2,200
+0.5%
GBX 2,800
+27.3%
-5.1%£945.27M£230.77M81.28734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500

Related Companies and Tools


This page (LON:INHC) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners